Article

An Ensemble-Base Machine Learning Approach to Predict 2- and 10-Year Breast Cancer

2026-02-22

Abstract excerpt

<title>Abstract</title> <p>Accurate prediction of breast cancer recurrence remains difficult because prognosis varies significantly across molecular subtypes, and genomic tests are often expensive or unavailable. As a result, many patients are assigned to broad risk categories that may lead to overtreatment or undertreatment. This underscores the need for scalable, affordable, and interpretable prognostic tools....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 45db6762-5544-5359-965d-2564c982a791
DOI: 10.21203/rs.3.rs-8374118/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

An Ensemble-Base Machine Learning Approach to Predict 2- and 10-Year Breast CancerDOI 10.21203/rs.3.rs-8374118/v1Read

Multimodal Prediction of Breast Cancer Recurrence Assays and Risk of RecurrenceSemantic proximity Read

Hematologic Biomarkers and AI in Breast Cancer: A New Frontier for Risk Stratification and Treatment Response PredictionSemantic proximity Read

Epigenetic profile drives accurate survival prediction in breast cancer via a multi-omics machine learning modelSemantic proximity Read

Epigenetic profile drives accurate survival prediction in breast cancer via a multi-omics machine learning modelSemantic proximity Read

Hematologic Biomarkers and AI in Breast Cancer: A New Frontier for Risk Stratification and Treatment Response PredictionSemantic proximity Read

Machine learning predicts rapid relapse of triple negative breast cancerSemantic proximity Read

Deep Learning on Histopathological Images to Predict Breast Cancer Recurrence Risk and Chemotherapy BenefitSemantic proximity Read

Multimodal histopathologic models stratify hormone receptor-positive early breast cancerSemantic proximity Read

Machine learning-driven identification and immunohistochemical validation of an integrated immune-inflammatory phenotype for disease-free survival stratification in breast cancer.Semantic proximity Read

Estimated survival outcomes and absolute chemotherapy treatment benefit using PREDICT Tool® and EndoPredict®, in hormone-positive early-stage breast cancer.Semantic proximity Read

COMBINE: A Comprehensive Multi-Omics Approach for Improving Breast Cancer Prognosis Classification in African American WomenSemantic proximity Read

Genomic Features of Rapid Versus Late Relapse in Triple Negative Breast Cancer Semantic proximity Read